SHIRATORI, Y. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000, 132, 517-524
YOSHIDA, H. Interferon therapy reduces the risk for hepatocellular carcinoma : national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med. 1999, 131, 174-181
DIENSTAG, JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002, 36, S152-S160
WAI, CT. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38, 518-526